BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18082198)

  • 1. Association of polymorphisms in TGFB1 and prostate cancer prognosis.
    Brand TC; Bermejo C; Canby-Hagino E; Troyer DA; Baillargeon J; Thompson IM; Leach RJ; Naylor SL
    J Urol; 2008 Feb; 179(2):754-8. PubMed ID: 18082198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
    Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
    Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
    JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlations of polymorphisms of TGFB1 and TGFBR2 genes to genetic susceptibility to gastric cancer].
    Zhou Y; Jin GF; Jiang GJ; Wang HM; Tan YF; Ding WL; Wang LN; Chen WS; Ke Q; Shen J; Xu YC; Shen HB
    Ai Zheng; 2007 Jun; 26(6):581-5. PubMed ID: 17562261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.
    Pierorazio PM; Ross AE; Lin BM; Epstein JI; Han M; Walsh PC; Partin AW; Pavlovich CP; Schaeffer EM
    BJU Int; 2012 Oct; 110(8):1122-8. PubMed ID: 22373045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
    Pierorazio PM; Lin BM; Mullins JK; Hyndman ME; Schaeffer EM; Han M; Partin AW; Pavlovich CP
    Urol Oncol; 2013 Jul; 31(5):589-94. PubMed ID: 21664838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFB1 Functional Gene Polymorphisms (C-509T and T869C) in the Maternal Susceptibility to Pre-eclampsia in South Indian Women.
    Deepthi G; Chaithri PK; Latha P; Rani VU; Rahman PF; Jahan P
    Scand J Immunol; 2015 Oct; 82(4):390-7. PubMed ID: 26173679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B; Angaji SA; Abolhasani M
    BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.
    Beuten J; Garcia D; Brand TC; He X; Balic I; Canby-Hagino E; Troyer DA; Baillargeon J; Hernandez J; Thompson IM; Leach RJ; Naylor SL
    J Urol; 2009 Oct; 182(4):1614-20. PubMed ID: 19683737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Herrera-Ramos E; Rodríguez-Gallego C; Rodríguez-Melcón JI; Lara PC
    BMC Med Genet; 2014 Dec; 15():143. PubMed ID: 25540025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
    Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
    Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt.
    Kamal H; Hussein G; Hassoba H; Mosaad N; Gad A; Ismail M
    Acta Cardiol; 2010 Apr; 65(2):177-83. PubMed ID: 20458825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
    Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
    Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Family History on Stage and Survival of Gastric Cancer According to the
    Kim HJ; Kwon M; Kim N; Lee JB; Won S
    Gut Liver; 2020 Jan; 14(1):79-88. PubMed ID: 31905487
    [No Abstract]   [Full Text] [Related]  

  • 17. No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity.
    Reuther S; Metzke E; Bonin M; Petersen C; Dikomey E; Raabe A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):460-5. PubMed ID: 22592044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.
    Peters CA; Stock RG; Cesaretti JA; Atencio DP; Peters S; Burri RJ; Stone NN; Ostrer H; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):752-9. PubMed ID: 17689884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.
    Jin G; Deng Y; Miao R; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Wang L; Chen W; Shen J; Wang X; Xu Y; Shen H
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):345-51. PubMed ID: 17680270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
    Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
    J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.